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Abstract 
We demonstrate a strategy for label-free protein detection through monitoring the Surface Enhanced 
Raman Spectrum of an aptamer probe attached to a gold nanoshell. Low limit of detection and 
minimal non-specific binding show potential for in-vitro and in-vivo assays. 
 
Introduction 
The ability to measure molecular binding events in real time, without labeling, is critically important 
in aiding our understanding of biological processes.
1
 In this paper we demonstrate that the binding 
between an aptamer and unlabelled protein can be detected by measuring changes in the surface 
enhanced Raman spectroscopy (SERS) signal of the aptamer caused by conformational changes 
which arise from formation of an aptamer/protein complex. While Raman spectroscopy has huge 
potential for probing such biomolecular systems,
2
 it has historically suffered from low signal 
intensities. High laser power can often compensate for low intrinsic signal, but can often lead to 
photo-damage of the sample. SERS is an alternative Raman technique which uses the plasmon 
resonance of noble metal particles or nanoscale surface structures to increase the Raman signal from 
analytes near the surface and therefore requires lower laser power, shorter acquisition times, and is 
increasingly valuable for measuring Raman spectra from dilute or photosensitive samples. SERS can 
be used to measure spectra from sensitive biological samples and has been applied in investigations of 
the live cell intracellular environment.
3
 Novel SERS substrates which exhibit high enhancement 
factors can be designed for specific purposes, e.g. core shell particles, resonant at near IR wavelengths 
are suitable for biomedical applications
4
 and we have recently shown that such particles can be 
introduced to mouse fibroblast cells in a controllable non-toxic way for the measurement of SERS 
spectra.
5
 
Biomolecular detection has been demonstrated using several approaches which facilitate SERS on 
nanoscale roughened noble metal surfaces or by using nanoparticles in a “sandwich” format.7 A few 
approaches for SERS detection of proteins have used aptamers, which are highly specific 
oligonucleotide probes
8
 that bind target molecules with high specificity. In these cases, Raman active 
dyes are generally attached to one end of the aptamer and are drawn closer to the surface of the SERS 
substrate during binding of the target protein leading to a large enhancement of the dye spectrum.
9
 
Perhaps the best characterized aptamer is the thrombin binding aptamer (TBA)
 
which can be used as 
an inhibitor of blood coagulation.
10,11
 The wealth of characterization data available for this aptamer 
makes it an ideal candidate to use as a model-system for development of new detection methods. 
Furthermore, thrombin is an important regulator of the cascade of reactions which lead to blood clot 
formation. Blood clots cause an estimated 25,000 deaths in the UK per year and recent clinical 
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guidelines have suggested that evaluation of the risk of clot formation could significantly reduce this 
toll. A simple, sensitive test of thrombin levels could be a valuable tool in such evaluations.
12 
 
 
Figure 1. a) Sketch shows the assembled mixed monolayer of prehybridized TBA oligonucleotide 
and MCH and the model for the detection. b) AFM image of NS aggregates used for SERS in this 
work. The clusters shown consist of two self-assembled layers with a size of ca. 0.5 μm. 
 
Since aptamer-protein binding often leads to a change in the aptamer structure, we speculate that we 
could use changes in the SERS spectrum of the aptamer to signal protein binding. Furthermore, since 
the vibrational spectra of proteins are distinct from those of nucleic acids, we might expect to see a 
difference between the spectrum of the aptamer and the spectrum of the aptamer-protein complex. 
Here we report the results of an investigation into whether we can directly view either the structural 
change of TBA on interaction with thrombin, or see new peaks in the sensor spectrum as a result of 
protein binding (Figure 1a). The system we used consisted of commercially available 152±6 nm (as 
determined by SEM)
5
 diameter gold nanoshells with a maximum absorbance at 780 nm (Auroshell
TM
, 
Nanospectra Inc., US) aggregates attached to amino-silane functionalised glass slides (UV-Vis 
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spectrum in Figure S1).
13
 Aggregation on the glass-surface leads to ca. 0.5 μm particle islands 
consisting of aggregates such that the particles are separated from each other by about 0-25 nm 
according to AFM measurements (Fig. S2). Figure 1b shows the aggregates in an area where 
measurements were conducted.  
 The oligonucleotides were conjugated covalently onto the gold surface by a 5’-C6-thiol linker.14 Non-
specific binding of DNA or proteins to the gold surface was reduced by blocking any unreacted 
surface sites with a self-assembled monolayer of mercapto-hexanol (MCH)
15
 (details in supporting 
info).  
The G-quadruplex, is an important feature of the aptamer/protein complex of the TBA oligonucleotide 
and human α thrombin and is stabilized by cations such as K+ or Mg2+. The buffer used in this study 
consists of 10 mM K
+
 and Mg
2+
 and 140 mM NaCl at a pH of 7.5 (supporting info). During 
interaction with the protein, the aptamer adopts a stacked G-quadruplex structure forming a “rocking 
chair” like shape.11 Representative Raman spectra of NS, NS covered with mercaptohexanol, aptamer 
conjugated-NS with mercaptohexanol blocking layer (NSTBA) in binding buffer; NSTBA after 30 
min incubation with different control samples [bovine serum albumin (BSA) 10 μM, human serum 
(HS) 1% and insulin 0.6 μM] and after incubation with target protein thrombin in binding buffer are 
shown in Figure 2. Raman measurements were carried out using a 785 nm laser exciting with power 
of 0.03±0.02 mW and acquisition times of 10 seconds (details in supporting info) on a Renishaw 
InVia Raman microscope. All measurements were made using a 50X water immersion objective in 
buffered solutions. In the case of NS and NS-MCH, the spectra show no detectable signal. The spectra 
of the completed NSTBA sensor show only weak signals with a prominent and stable feature at 
1089 cm
-1
 assignable to the DNA O-P-O backbone stretch. Spectra of the sensor incubated with non-
target proteins show weak signals similar to the background spectrum of the sensing platform. 
 
 
← Figure 2. Spectral changes 
caused by human α-thrombin (10 
nM) binding to NSTBA sensor. The 
dominant peaks can be assigned to 
DNA vibrational modes (see text). 
Controls with BSA (10 mg/ml), 
insulin 600 nM and 1% human 
serum show no non-specific protein 
binding. Lower three spectra show 
spectra of NS, NS plus blocking 
agent (mercaptohexanol) and the 
fully assembled NSTBA sensor. 
Spectra are averages of 10 
acquisitions. 
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Only incubation of the cognate target protein leads to a measurable change in the spectrum of the 
NSTBA sensor. Spectra measured when the sensor was incubated with 10 nM human thrombin show 
increases in signal at 822 cm
-1
, 1140 cm
-1
 and 1558 cm
-1
. These can be assigned to the combined C2'-
endo and C3'-endo modes of the 2'-deoxyribose sugars,
 
the C-O-C stretch at 1140 cm
-1
 and guanine 
ring modes at 1558 cm
-1
. At 1480 cm
-1
 we observe another feature with lower intensity which can also 
be assigned to a guanine ring mode.
16
 Further signal increases can be assigned to vibrational modes of 
protein, such as the amide III backbone vibration at 1220 cm
-1
, CH2 stretching mode at 1440-1460 cm
-
1
 or tyrosine aromatic ring vibrations at 1610 cm
-1
.
17 
An experiment using a control oligonucleotide 
lacking specific thrombin binding capability did not show any changes on thrombin incubation 
(Figure S3). Further SERS measurements of thrombin, guanosine- and thymidine-triphosphate on NS 
(Figure S4) confirm these spectral assignments. Since TBA is known to adopt a G-quadruplex 
conformation when it binds to thrombin, we speculate that the strong spectral changes detailed above 
are caused by the switch from a relatively unstructured oligo to the G-quadruplex structure. This 
suggests that formation of a G-quadruplex positions key nucleotides closer to the gold surface and in a 
better position to interact with surface plasmons. In previous studies by Halas et al.
18
 it was shown 
that the hybridization of oligonucleotides leads to changes in SERS spectra. The same authors have 
also described the correlation between dsDNA orientation and SERS signal intensity and found signal 
increases depending on the angle between the molecule and the surface.
19 
In order to further investigate the spectral features attributable to G-quadruplex formation we used an 
oligonucleotide which has been specifically selected for G-quadruplex formation.
20
 The SERS 
spectrum shows peaks at 820 cm
-1
, 1132 cm
-1
, 1480 cm
-1
 and 1560 cm
-1
. These peaks can be assigned 
in a similar way to the prominent peaks of the TBA/thrombin complex with the features at 1480 cm
-1
 
and 1560 cm
-1
 exhibiting altered intensity ratios (Figure 3). These slight differences in intensity are to 
be expected between different macromolecules since their relative orientations to the surface may 
differ. We also investigated the temperature dependent behavior of this control oligonucleotide to 
demonstrate the correlation between SERS signal and secondary structure formation. A melting 
experiment shown in Figure 3 demonstrates that the spectral features which we attribute to the G-
quadruplex structure can be reversibly eliminated and regained through temperature cycling. 
(turn to next page →) 
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Figure 3. To show the relationship between the oligonucleotide secondary structure and SERS signal 
we increased the temperature and observed the change in Raman spectrum. Spectra show averages of 
20 spectra with acquisition times of 10 sec. Temperatures were increased in 10 °C steps from 30 °C 
up to 70 °C and the intensity of the marker bands decreased in intensity. Cooling back to RT after the 
70 °C measurement gave spectra with the original high intensity signals and we therefore suggest that 
the oligo refolds to its original structure at low temperature.  
 
To study the reproducibility and the re-usability of the sensor, successive washing steps were 
performed with buffer which disrupts the aptamer-protein interaction (details in supporting 
information). Washing led to the same low intensity signal which we measured prior to protein 
incubation. On reincubation with thrombin (10 nM), the characteristic SERS spectrum of the 
aptamer/protein complex returned. This cycle was repeated and the SERS changes shown to be 
reproducible (Figure 4a). This figure also shows a comparison of the control measurements with the 
binding signal. Furthermore, we observe the same spectral changes when incubating the sensor with 
thrombin doped into human serum (Figure 4a) confirming that we can observe this specific 
biomolecular interaction even in a complex biological matrix (the data represented in figure 4a are 
shown as a standard histogram with error bars in figure S5). Using this approach, we can reliably 
detect thrombin down to 0.1 fM (Figure 4b) as experimentally determined by using thrombin 
concentrations between 500 yM and 50 µM.  
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Figure 4. a) Washing and target incubation cycles of NSTBA with 10 nM thrombin. Graph shows 
SERS intensities of 3 peaks associated with conformational switching and one at 1089 cm-1 which is 
used as a control peak. Peak intensities are highly reproducibly at every incubation cycle. A further 
incubation in which 10 nM thrombin was dissolved in a 1% solution of human serum produced 
similar peak intensities. Control experiments incubating only with bovine serum albumin, insulin and 
human serum do not show any increased signals compared to the washed sensor. b) The limit of 
detection was determined by integrating the peaks at 820 cm
-1
, 1140 cm
-1
 and 1558 cm
-1
 of 10 spectra 
and normalized to the integral of the constant peak at 1089 cm
-1
. Errorbars represent a single standard 
deviation. The red line indicates the blank measurement plus 3 standard deviations. The datapoint at 
50 aM is the first over the limit of detection threshold and we state a confident limit of detection of 
0.1 fM.  
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We have shown an easy and versatile approach for the label-free study of biomolecular interactions. 
Our example demonstrates sensitive, specific protein detection using the G-quadruplex TBA with NS 
aggregates as substrate. The advantage of our approach is that the detection is independent of a 
separate Raman reporter and opens the door to various sensor applications such as the multiplexed 
detection of proteins in an array. Since we have recently demonstrated the utility of nanoshells for 
intracellular SERS
5
 we expect that the combination of these two discoveries will enable the study of 
biomoelecular interactions in the cytoplasm of eukaryotic cells. 
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